2015 Q4 Form 10-Q Financial Statement
#000119312515368169 Filed on November 05, 2015
Income Statement
Concept | 2015 Q4 | 2015 Q3 | 2014 Q4 |
---|---|---|---|
Revenue | $338.4M | $326.5M | $300.5M |
YoY Change | 12.61% | 8.72% | -0.56% |
Cost Of Revenue | $192.5M | $186.8M | $171.4M |
YoY Change | 12.31% | 9.76% | -3.92% |
Gross Profit | $145.9M | $139.7M | $129.2M |
YoY Change | 12.93% | 7.38% | 4.36% |
Gross Profit Margin | 43.11% | 42.79% | 43.0% |
Selling, General & Admin | $125.0M | $116.2M | $107.2M |
YoY Change | 16.6% | 8.19% | -10.37% |
% of Gross Profit | 85.68% | 83.18% | 82.97% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $4.200M | $4.600M | $6.200M |
YoY Change | -32.26% | -29.23% | -28.74% |
% of Gross Profit | 2.88% | 3.29% | 4.8% |
Operating Expenses | $129.2M | $120.8M | $113.4M |
YoY Change | 13.93% | 6.15% | -8.84% |
Operating Profit | $16.70M | $16.72M | $15.80M |
YoY Change | 5.7% | 2.87% | -2733.33% |
Interest Expense | $200.0K | $4.936M | -$1.800M |
YoY Change | -111.11% | 65.08% | 28.57% |
% of Operating Profit | 1.2% | 29.53% | -11.39% |
Other Income/Expense, Net | $5.800M | -$1.675M | $1.500M |
YoY Change | 286.67% | -26.95% | -250.0% |
Pretax Income | $22.60M | $15.04M | $14.50M |
YoY Change | 55.86% | 7.77% | -201.4% |
Income Tax | $9.600M | $6.465M | $5.200M |
% Of Pretax Income | 42.48% | 42.99% | 35.86% |
Net Earnings | $12.90M | $8.400M | $9.100M |
YoY Change | 41.76% | 0.0% | -194.79% |
Net Earnings / Revenue | 3.81% | 2.57% | 3.03% |
Basic Earnings Per Share | $0.39 | $0.25 | $0.28 |
Diluted Earnings Per Share | $0.38 | $0.25 | $0.28 |
COMMON SHARES | |||
Basic Shares Outstanding | 33.69M shares | 33.13M shares | |
Diluted Shares Outstanding | 33.63M shares |
Balance Sheet
Concept | 2015 Q4 | 2015 Q3 | 2014 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $27.50M | $57.10M | $8.000M |
YoY Change | 243.75% | 938.18% | -53.76% |
Cash & Equivalents | $27.50M | $57.05M | $8.032M |
Short-Term Investments | |||
Other Short-Term Assets | $22.70M | $5.641M | $19.71M |
YoY Change | 15.18% | -83.41% | 82.74% |
Inventory | |||
Prepaid Expenses | $8.493M | ||
Receivables | $125.0M | $121.7M | $99.33M |
Other Receivables | $0.00 | $0.00 | $15.00M |
Total Short-Term Assets | $175.3M | $216.4M | $135.6M |
YoY Change | 29.32% | 52.0% | -33.96% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $42.70M | $41.49M | $137.5M |
YoY Change | -68.94% | -70.67% | -13.56% |
Goodwill | $261.7M | $211.1M | $205.6M |
YoY Change | 27.29% | -1.58% | |
Intangibles | $44.00M | $33.15M | $33.20M |
YoY Change | 32.53% | -9.54% | |
Long-Term Investments | $29.70M | ||
YoY Change | 28.02% | ||
Other Assets | $158.0M | $164.3M | $33.16M |
YoY Change | 376.46% | 3.53% | 26.17% |
Total Long-Term Assets | $506.4M | $450.0M | $534.2M |
YoY Change | -5.2% | -16.64% | 2.51% |
TOTAL ASSETS | |||
Total Short-Term Assets | $175.3M | $216.4M | $135.6M |
Total Long-Term Assets | $506.4M | $450.0M | $534.2M |
Total Assets | $681.7M | $666.4M | $669.7M |
YoY Change | 1.79% | -2.32% | -7.8% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $25.68M | $24.23M | $16.06M |
YoY Change | 59.95% | 25.11% | -20.27% |
Accrued Expenses | $71.97M | $69.19M | $56.33M |
YoY Change | 27.76% | -56.68% | -2.16% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $5.000M | $3.800M | $12.00M |
YoY Change | -58.33% | -68.33% | -13.67% |
Total Short-Term Liabilities | $175.2M | $171.2M | $162.3M |
YoY Change | 7.93% | -10.39% | -48.04% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $91.60M | $96.30M | $104.4M |
YoY Change | -12.26% | -5.87% | 216.36% |
Other Long-Term Liabilities | $4.500M | $4.998M | $5.285M |
YoY Change | -14.85% | -13.05% | -37.9% |
Total Long-Term Liabilities | $91.60M | $101.3M | $109.7M |
YoY Change | -16.49% | -6.25% | 164.23% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $175.2M | $171.2M | $162.3M |
Total Long-Term Liabilities | $91.60M | $101.3M | $109.7M |
Total Liabilities | $274.6M | $272.5M | $272.0M |
YoY Change | 0.98% | -8.91% | -23.15% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$67.81M | -$64.79M | |
YoY Change | 4.66% | -16.47% | |
Common Stock | $504.3M | $495.8M | $481.8M |
YoY Change | 4.68% | 2.96% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $26.97M | $22.03M | $19.86M |
YoY Change | 35.78% | 9.26% | |
Treasury Stock Shares | 1.180M shares | 1.054M shares | 975.0K shares |
Shareholders Equity | $409.6M | $393.1M | $397.2M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $681.7M | $666.4M | $669.7M |
YoY Change | 1.79% | -2.31% | -7.8% |
Cashflow Statement
Concept | 2015 Q4 | 2015 Q3 | 2014 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $12.90M | $8.400M | $9.100M |
YoY Change | 41.76% | 0.0% | -194.79% |
Depreciation, Depletion And Amortization | $4.200M | $4.600M | $6.200M |
YoY Change | -32.26% | -29.23% | -28.74% |
Cash From Operating Activities | $20.10M | $30.70M | $4.600M |
YoY Change | 336.96% | 20.87% | -45.24% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$3.400M | -$1.300M | -$2.100M |
YoY Change | 61.9% | 62.5% | -83.46% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$44.10M | -$6.700M | -$3.000M |
YoY Change | 1370.0% | -770.0% | -266.67% |
Cash From Investing Activities | -$47.50M | -$8.100M | -$5.100M |
YoY Change | 831.37% | -4150.0% | -53.64% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -2.000M | 1.100M | 3.100M |
YoY Change | -164.52% | -103.51% | -113.08% |
NET CHANGE | |||
Cash From Operating Activities | 20.10M | 30.70M | 4.600M |
Cash From Investing Activities | -47.50M | -8.100M | -5.100M |
Cash From Financing Activities | -2.000M | 1.100M | 3.100M |
Net Change In Cash | -29.40M | 23.70M | 2.600M |
YoY Change | -1230.77% | -515.79% | -109.89% |
FREE CASH FLOW | |||
Cash From Operating Activities | $20.10M | $30.70M | $4.600M |
Capital Expenditures | -$3.400M | -$1.300M | -$2.100M |
Free Cash Flow | $23.50M | $32.00M | $6.700M |
YoY Change | 250.75% | 22.14% | -68.25% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.01 | ||
amed |
Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
|
0 | ||
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | ||
CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
162323000 | |
CY2014Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
5285000 | |
CY2015Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4998000 | |
CY2015Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
171214000 | |
CY2015Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
74050000 | |
dei |
Entity Registrant Name
EntityRegistrantName
|
AMEDISYS INC | ||
dei |
Trading Symbol
TradingSymbol
|
AMED | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000896262 | ||
CY2015Q3 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
129992000 | |
CY2015Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
33691200 | shares |
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2015 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | ||
dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
Yes | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2014Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
0 | |
CY2014Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
0 | |
CY2015Q3 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
326450000 | |
CY2014Q3 | us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
300281000 | |
us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
942174000 | ||
CY2015Q3 | us-gaap |
Cost Of Services
CostOfServices
|
186772000 | |
CY2014Q3 | us-gaap |
Cost Of Services
CostOfServices
|
170159000 | |
CY2015Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
69993000 | |
CY2014Q3 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
69461000 | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3197000 | ||
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
114734000 | ||
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
110240000 | ||
CY2014Q3 | amed |
Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
|
4183000 | |
amed |
Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
|
13318000 | ||
CY2015Q3 | amed |
Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
|
4646000 | |
amed |
Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
|
15798000 | ||
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
77268000 | ||
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
2208000 | ||
CY2015Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
309735000 | |
CY2014Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
284033000 | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
968036000 | ||
us-gaap |
Costs And Expenses
CostsAndExpenses
|
894790000 | ||
CY2015Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
16715000 | |
CY2014Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
16248000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-25862000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
9236000 | ||
CY2015Q3 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
7000 | |
CY2014Q3 | us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
24000 | |
us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
33000 | ||
us-gaap |
Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
|
46000 | ||
CY2015Q3 | us-gaap |
Interest Expense
InterestExpense
|
4936000 | |
CY2014Q3 | us-gaap |
Interest Expense
InterestExpense
|
2990000 | |
us-gaap |
Interest Expense
InterestExpense
|
9778000 | ||
us-gaap |
Interest Expense
InterestExpense
|
5603000 | ||
CY2015Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
1924000 | |
CY2014Q3 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
563000 | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
8701000 | ||
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
2234000 | ||
CY2015Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1330000 | |
CY2014Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
110000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
544000 | ||
CY2015Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1675000 | |
CY2014Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2293000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
2918000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2779000 | ||
CY2015Q3 | us-gaap |
Minority Interest
MinorityInterest
|
843000 | |
CY2015Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
24226000 | |
CY2014Q4 | us-gaap |
Preferred Stock Value Outstanding
PreferredStockValueOutstanding
|
0 | |
CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | |
CY2015Q3 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
1053991 | shares |
CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34569526 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
33594572 | shares |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7637000 | ||
CY2014Q3 | amed |
Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
|
6515000 | |
amed |
Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
|
9370000 | ||
CY2014Q4 | us-gaap |
Assets
Assets
|
669742000 | |
CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
135558000 | |
CY2015Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
41485000 | |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8032000 | |
CY2014Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
16056000 | |
CY2015Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
33150000 | |
CY2014Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
8493000 | |
CY2014Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
19708000 | |
CY2015Q3 | us-gaap |
Goodwill
Goodwill
|
211109000 | |
CY2014Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
75553000 | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
137455000 | |
CY2015Q3 | us-gaap |
Assets Current
AssetsCurrent
|
216441000 | |
CY2015Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
121744000 | |
CY2014Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
56329000 | |
CY2014Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
12000000 | |
CY2014Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
33193000 | |
CY2015Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
5641000 | |
CY2014Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
99325000 | |
CY2015Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
57051000 | |
CY2015Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
69188000 | |
CY2015Q3 | us-gaap |
Preferred Stock Value Outstanding
PreferredStockValueOutstanding
|
0 | |
CY2015Q3 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
35000 | |
CY2014Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
15000 | |
CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
669742000 | |
CY2014Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
397762000 | |
CY2014Q4 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
35000 | |
CY2014Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
19860000 | |
CY2014Q4 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
2385000 | |
CY2014Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
974954 | shares |
CY2015Q3 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
0 | |
CY2015Q3 | us-gaap |
Liabilities
Liabilities
|
272462000 | |
CY2015Q3 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
3750000 | |
CY2015Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
495827000 | |
CY2015Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
22029000 | |
CY2015Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
15000 | |
CY2015Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
393131000 | |
CY2015Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
393974000 | |
CY2015Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
666436000 | |
CY2014Q4 | us-gaap |
Minority Interest
MinorityInterest
|
595000 | |
CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-64785000 | |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
397167000 | |
CY2015Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
2075000 | |
CY2014Q3 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | |
CY2015Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | shares |
CY2014Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
146438000 | |
CY2015Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
25379000 | |
CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2015Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2015Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
0 | |
CY2015Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
14753000 | |
CY2014Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
14317000 | |
CY2014Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
25374000 | |
CY2015Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
140363000 | |
CY2015Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34726207 | shares |
CY2015Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
33672216 | shares |
CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
60000000 | shares |
us-gaap |
Cost Of Services
CostOfServices
|
533432000 | ||
us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
224032000 | ||
CY2015Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3060000 | |
CY2014Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1697000 | |
CY2014Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
32018000 | |
CY2015Q3 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
19650000 | |
us-gaap |
Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
|
904026000 | ||
us-gaap |
Cost Of Services
CostOfServices
|
519686000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
3962000 | ||
us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
209797000 | ||
CY2015Q3 | amed |
Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
|
3638000 | |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
8439000 | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
117000 | ||
amed |
Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
|
22109000 | ||
us-gaap |
Interest Paid
InterestPaid
|
5598000 | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-12383000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-1554000 | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
13000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
668000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-4081000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
9882000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-70129000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
67530000 | ||
CY2014Q3 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.81 | pure |
CY2014Q4 | us-gaap |
Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
|
18800000 | |
CY2015Q3 | amed |
Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
|
0.20 | pure |
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
15040000 | |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
13955000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-22944000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
6457000 | ||
CY2015Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
6465000 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-7560000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2483000 | ||
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
8575000 | |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
8597000 | |
us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
-15384000 | ||
us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
3974000 | ||
CY2015Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
0 | |
CY2014Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
0 | |
us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
0 | ||
CY2015Q3 | us-gaap |
Profit Loss
ProfitLoss
|
8575000 | |
CY2014Q3 | us-gaap |
Profit Loss
ProfitLoss
|
8597000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-15384000 | ||
CY2015Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
135000 | |
CY2014Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
158000 | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
548000 | ||
CY2015Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8440000 | |
CY2014Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8439000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-15932000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
3641000 | ||
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.25 | |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.26 | |
us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.48 | ||
us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.12 | ||
CY2015Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | |
CY2014Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | |
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.01 | ||
CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.25 | |
CY2014Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.26 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.48 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | ||
CY2015Q3 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.25 | |
CY2014Q3 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.26 | |
us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.48 | ||
us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.12 | ||
CY2015Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | |
CY2014Q3 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | |
CY2015Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.25 | |
CY2014Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.26 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.48 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.11 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | ||
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-15932000 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-216000 | ||
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
3857000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-945000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-9547000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5848000 | ||
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17303000 | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
13392000 | ||
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
9370000 | ||
us-gaap |
Pension Expense
PensionExpense
|
4544000 | ||
us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
184000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-286000 | ||
us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
413000 | ||
us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
63400000 | ||
us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
200800000 | ||
us-gaap |
Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
|
4233000 | ||
us-gaap |
Pension Expense
PensionExpense
|
4682000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-2762000 | ||
us-gaap |
Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
|
2967000 | ||
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
190800000 | ||
us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
2561000 | ||
us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
3421000 | ||
amed |
Increase Decrease In Us Department Of Justice Settlement Accrual
IncreaseDecreaseInUsDepartmentOfJusticeSettlementAccrual
|
-115000000 | ||
amed |
Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
|
0 | ||
amed |
Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
|
300000 | ||
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
78400000 | ||
us-gaap |
Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
|
5000000 | ||
us-gaap |
Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
|
0 | ||
amed |
Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
|
0 | ||
amed |
Noncash Or Part Noncash Sale Acquisition Of Noncontrolling Interests
NoncashOrPartNoncashSaleAcquisitionOfNoncontrollingInterests
|
-1549000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
49019000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
87741000 | ||
us-gaap |
Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
|
1077000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-12701000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
803000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
8597000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
774000 | ||
CY2015Q3 | us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.79 | pure |
us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
5135000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
31788000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
9152000 | ||
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
67371000 | ||
us-gaap |
Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
|
1500000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
15798000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
22149000 | ||
amed |
Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
|
2513000 | ||
amed |
Deferred Debt Issuance Costs Written Off
DeferredDebtIssuanceCostsWrittenOff
|
488000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
3000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | ||
us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
5800000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
17969000 | ||
us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
19000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-19859000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
399000 | ||
us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
1591000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-18863000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-9162000 | ||
us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
521000 | ||
us-gaap |
Interest Paid
InterestPaid
|
4771000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
6357000 | ||
us-gaap |
Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
|
104000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-4174000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
89000 | ||
us-gaap |
Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
|
9000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1885000 | ||
us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
1875000 | ||
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
100000000 | ||
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
2553000 | ||
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
10904000 | ||
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
103000000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-11761000 | ||
CY2014Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5542000 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates</font></p><p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and </font><font style="font-family:Times New Roman;font-size:10pt;">reporting policies conform with </font><font style="font-family:Times New Roman;font-size:10pt;">U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited </font><font style="font-family:Times New Roman;font-size:10pt;">condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</font></p> | ||
CY2014Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
CY2014Q3 | amed |
Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
|
466000 | shares |
amed |
Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
|
0 | shares | |
amed |
Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
|
496000 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
107000 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares | |
CY2015Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
89000 | shares |
us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
901000 | ||
CY2014Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
116400000 | |
CY2015Q3 | us-gaap |
Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
|
24400000 | |
CY2014Q4 | us-gaap |
Cost Method Investments
CostMethodInvestments
|
5000000 | |
us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.80 | pure | |
us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.82 | pure | |
amed |
Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
|
0.98 | pure | |
amed |
Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
|
0.98 | pure | |
amed |
Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
|
0.10 | pure | |
amed |
Second Threshold Of Services Required
SecondThresholdOfServicesRequired
|
14 | Number_of_Visits | |
amed |
Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
|
5 | Number_of_Visits | |
CY2015Q3 | amed |
Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
|
0.98 | pure |
CY2015Q3 | amed |
Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
|
0.50 | pure |
CY2015Q3 | us-gaap |
Cost Method Investments
CostMethodInvestments
|
0 | |
CY2015Q3 | us-gaap |
Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
|
34 | States |
CY2015Q3 | amed |
Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
|
0.50 | pure |
amed |
Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
|
60 | ||
amed |
Episodes In Progress That Begin During Reporting Period
EpisodesInProgressThatBeginDuringReportingPeriod
|
60 | ||
amed |
First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
|
6 | Number_of_Visits | |
amed |
Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
|
20 | Number_of_Visits | |
amed |
Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
|
0.99 | pure | |
CY2014Q3 | amed |
Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
|
0.96 | pure |
amed |
Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
|
0.1 | pure | |
amed |
Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
|
365 | ||
CY2014 | amed |
Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
|
0.69 | pure |
amed |
Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
|
0.6 | pure | |
amed |
Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
|
0.5 | pure | |
amed |
Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
|
120 | ||
amed |
Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
|
60 | ||
CY2015Q3 | amed |
Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
|
1500000 | |
amed |
Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
|
0.65 | pure | |
CY2014Q3 | amed |
Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
|
1400000 | |
amed |
Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
|
4000000 | ||
amed |
Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
|
4100000 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32957000 | shares | |
CY2015Q3 | us-gaap |
Land
Land
|
0 | |
CY2014Q4 | us-gaap |
Land
Land
|
3200000 | |
CY2014Q4 | amed |
Buildingandleaseholdimprovements
Buildingandleaseholdimprovements
|
25300000 | |
CY2014Q4 | amed |
Equipmentandfurniture
Equipmentandfurniture
|
97200000 | |
CY2014Q4 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
158200000 | |
CY2014Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
283900000 | |
CY2015Q3 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
91900000 | |
CY2015Q3 | amed |
Equipmentandfurniture
Equipmentandfurniture
|
87900000 | |
CY2015Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
181900000 | |
CY2015Q3 | amed |
Buildingandleaseholdimprovements
Buildingandleaseholdimprovements
|
2100000 | |
CY2014Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
51000 | shares |
CY2015Q3 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
57000 | shares |
CY2015Q3 | amed |
Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
|
446000 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
983000 | shares | |
us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares | |
CY2015Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
33631000 | shares |
CY2015Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
33128000 | shares |
CY2014Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32468000 | shares |
CY2014Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32934000 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32957000 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
32690000 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
32194000 | shares | |
CY2015Q3 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
3600000 | |
CY2015Q3 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
0 | |
CY2015Q3 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
0 | |
CY2015Q3 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | |
CY2014Q3 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
0 | |
CY2014Q3 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
0 | |
CY2014Q3 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
0 | |
us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
0 | ||
us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
0 | ||
amed |
Health Insurance Retention Limit
HealthInsuranceRetentionLimit
|
900000 | ||
amed |
Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
|
500000 | ||
amed |
Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
|
300000 | ||
us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | Segments | |
amed |
General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
|
332100000 | ||
CY2015Q3 | amed |
General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
|
112600000 | |
CY2014Q3 | amed |
General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
|
103200000 | |
CY2015Q3 | us-gaap |
Long Term Debt
LongTermDebt
|
100000000 | |
CY2015Q3 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
96300000 | |
CY2014Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
104400000 | |
CY2015Q3 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
300000000 | |
us-gaap |
Debt Issuance Costs
DebtIssuanceCosts
|
2400000 | ||
CY2015Q3 | amed |
Total Leverage Ratio
TotalLeverageRatio
|
1.0 | pure |
us-gaap |
Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
|
2500000 | ||
CY2015Q3 | amed |
Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
|
3.2 | pure |
CY2015Q3 | amed |
Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
|
P5Y | |
amed |
General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
|
337500000 | ||
CY2015Q3 | us-gaap |
Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
|
75000000 |